Liminatus Pharma, Inc.
LIMN
$1.28
-$0.03-2.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -214.00K | -300.00 | -229.00K | -2.71M | |
| Total Depreciation and Amortization | 700.00 | -- | -- | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -1.27M | -- | -- | -- | |
| Change in Net Operating Assets | -7.49M | 300.00 | 88.00K | 1.61M | |
| Cash from Operations | -8.98M | 0.00 | -141.00K | -1.10M | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -775.00K | -- | -550.00K | -1.50M | |
| Cash from Investing | -775.00K | -- | -550.00K | -1.50M | |
| Total Debt Issued | 4.34M | -- | 700.00K | 2.24M | |
| Total Debt Repaid | -1.30M | -- | -- | -- | |
| Issuance of Common Stock | 10.56M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -2.56M | -- | -- | -36.00K | |
| Cash from Financing | 11.03M | -- | 700.00K | 2.20M | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 1.28M | -- | 9.00K | -400.30K | |